The current tetravalent dengue vaccine TAK-003, from the Japanese laboratory Takeda, is not likely to control the ongoing epidemic, according to the Pan American Health Organization (PAHO). The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results